THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION…
MaaT PharmaMay 14, 2024
MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the…
MaaT PharmaMay 6, 2024
MaaT Pharma to Hold Annual General Meeting on May 28, 2024 Lyon, France, April 22nd…
MaaT PharmaApril 22, 2024
MaaT Pharma Presents Positive 18-month Data for MaaT013 Showing a Clear Overall Survival Advantage in…
MaaT PharmaApril 15, 2024
MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the…
MaaT PharmaApril 9, 2024
MaaT Pharma Presents Promising Preclinical Data at AACR for MaaT034 Aiming To Improve Patients’ Responses…
MaaT PharmaApril 8, 2024
MaaT Pharma Announces Initiation of Coverage of its Stock by Gilbert Dupont/ Groupe Société Générale…
MaaT PharmaApril 5, 2024
MaaT Pharma Announces 2023 Annual Results and Provides a Business Overview The DSMB, based on…
MaaT PharmaMarch 28, 2024
MaaT Pharma Strengthens Executive Team Appointing Jonathan Chriqui as Chief Business Officer Lyon, France, March…
MaaT PharmaMarch 21, 2024
